RxSight, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving RxSight, Inc. now
Current reporting with the operating signal separated from the noise.
RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
The development tests whether RxSight, Inc. can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance
The story matters when it changes RxSight, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer
The story matters when it changes RxSight, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.RxSight, Inc. Announces Chief Financial Officer Transition
The story matters when it changes RxSight, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.RxSight, Inc. Reports Second Quarter 2025 Financial Results
The story matters when it changes RxSight, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Deadline Approaching: RxSight, Inc. (RXST) Investors Who Lost Money Urged to Contact Law Offices of Howard G. Smith
The story matters when it changes RxSight, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Law Offices of Frank R. Cruz Encourages RxSight, Inc. (RXST) Investors To Inquire About Securities Fraud Class Action
The story matters when it changes RxSight, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.RxSight, Inc. to Present at Bank of America Healthcare Conference on May 14, 2025
The story matters when it changes RxSight, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.RxSight, Inc. (RXST) Q4 2024 Earnings Call Transcript
Investors are testing whether RxSight, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest RXST filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
RxSight, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →